Willis Read-Button

Associate Director of Genomics Project Management at Merck

Willis Read-Button is a dynamic and entrepreneurial biomedical engineer with 11 years of experience in genomics research. He is skilled at designing and optimizing efficient systems, managing a wide range of projects, and working collaboratively across roles, groups, and institutions.

Willis pursued his B.S. in Biomedical Engineering at Trinity College-Hartford. His educational background provided a solid foundation for his career in the field.

With a rich and diverse work history, Willis has held key positions at reputable organizations. Currently, he serves as the Associate Director Genomics Project Management at Merck, where he leverages his expertise in the field.

Prior to his role at Merck, Willis gained valuable experience as a Consultant at Bioprocess Group, showcasing his versatility and adaptability in different work environments.

As a Co-Founder and Vice President of Operations at Genometry, Inc, Willis demonstrated his entrepreneurial spirit and leadership skills, laying the foundation for successful operations within the company.

During his time as a Co-Founder and Director of Operations at Genometry, Inc, Willis played a pivotal role in shaping the strategic direction of the organization and overseeing day-to-day activities.

Before his experiences at Genometry, Inc, Willis honed his research skills as a Research Associate II and Research Technician I at The Broad Institute of MIT & Harvard, where he contributed to groundbreaking genomics research.

His journey in the field began as a Student Research Assistant at Beth Israel Deaconess Medical Center, where he laid the groundwork for his future endeavors in genomics research.

Willis Read-Button's career trajectory showcases his dedication to advancing genomics research, his ability to lead and manage projects effectively, and his knack for fostering collaboration across various sectors.

With a strong educational background and a wealth of hands-on experience, Willis continues to be a driving force in the field of biomedical engineering and genomics research.